1. 0005 COMPARISON OF PACLITAXEL, CISPLATIN (TP), VERSUS PACLITAXEL, IFOSFAMIDE, CISPLATIN (TIP), AS NEOADJU-VANT CHEMOTHERAPY TO RADICAL SURGERY IN LOCALLY ADVANCED SQUAMOUS CELL CERVICAL CARCINOMA (LASCCC): THE SNAP-02 ITALIAN STUDY. (1st September 2005) Authors: Colombo, N.; Buda, A.; Parma, G.; Rulli, E.; Lissoni, A.; Floriani, I.; Fei, F.; Zola, P.; Katsaros, D.; Grassi, R.; Mangioni, C. Journal: International journal of gynecological cancer Issue: Volume 15(2005)Supplement 2 Page Start: 52 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 2006 A phase III multicenter trial comparing two different sequences of second/third line therapy (cetuximab/irinotecan followed by FOLFOX versus FOLFOX followed by cetuximab/irinotecan) in metastatic K-RAS wt colorectal cancer (mCC) patients, refractory to FOLFIRI/Bevacizumab). Issue 3 (September 2015) Authors: Cascinu, S.; Lonardi, S.; Rosati, G.; Nasti, G.; Zaniboni, A.; Romiti, A.; Aglietta, M.; Bilancia, D.; Iaffaioli, V.; Zagonel, V.; Giordano, M.; Corsi, D.; Ferraù, F.; Labianca, R.; Berardi, R.; Rulli, E.; Floriani, I. Journal: European journal of cancer Issue: Volume 51:Issue 3(2015:Feb.) Page Start: S329 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. LBA23FOLFOX4/XELOX in stage II–III colon cancer: Efficacy and safety results of the Italian Three Or Six Colon Adjuvant (TOSCA) trial. (18th September 2017) Authors: Labianca, R.; Lonardi, S.; Rosati, G.; Di Bartolomeo, M.; Ronzoni, M.; Pella, N.; Scartozzi, M.; Banzi, M.; Zampino, M.G.; Pasini, F.; Marchetti, P.; Cantore, M.; Zaniboni, A.; Rimassa, L.; Ciuffreda, L.; Barni, S.; Zagonel, V.; Maiello, E.; Rulli, E.; Sobrero, A. Journal: Annals of oncology Issue: Volume 28(2017)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Metronomic Chemotherapy in Triple-Negative Metastatic Breast Cancer: The Future Is Now?. (3rd December 2017) Authors: Cazzaniga, M. E.; Cortesi, L.; Ferzi, A.; Scaltriti, L.; Cicchiello, F.; Ciccarese, M.; Torre, S. Della; Villa, F.; Giordano, M.; Verusio, C.; Nicolini, M.; Gambaro, A. R.; Zanlorenzi, L.; Biraghi, E.; Casini, E.; Legramandi, L.; Rulli, E. Other Names: Harris Eleanor E. R. Academic Editor. Journal: International journal of breast cancer Issue: Volume 2017(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Oxaliplatin plus fluoropyrimidines as adjuvant therapy for colon cancer in older patients: A subgroup analysis from the TOSCA trial. (May 2021) Authors: Rosati, Gerardo; Lonardi, Sara; Galli, Fabio; Di Bartolomeo, Maria; Ronzoni, Monica; Zampino, Maria G.; Banzi, Maria; Zaniboni, Alberto; Pasini, Felice; Bozzarelli, Silvia; Garattini, Silvio K.; Ferrari, Daris; Montesarchio, Vincenzo; Mambrini, Andrea; Ciuffreda, Libero; Galli, Francesca; Puscedd... Journal: European journal of cancer Issue: Volume 148(2021) Page Start: 190 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗